Market Overview

Morning Market Movers

Related MNKD
Morning Market Losers
Benzinga's Top #PreMarket Losers
Pharmacyte Biotech Will Make You Rethink What's Possible in Treating Diabetes (Small Cap Network)
Related DRNA
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now
Dicerna Pharmaceuticals Submits Investigational New Drug (IND) Application for DCR-PH1, an Investigational Therapy for Primary Hyperoxaluria Type 1 (PH1)

MannKind (NASDAQ: MNKD) surged 13.50% to $11.35 following the Friday's conditional FDA approval for Afrezzaa.

Dicerna Pharmaceuticals (NASDAQ: DRNA) climbed 12.07% to $21.11 on promising clinical data for DCR-PH1.

Enventis (NASDAQ: ENVE) shares jumped 11.39% to $15.65 after the company announced its plans to merge with Consolidated Communications (NASDAQ: CNSL).

Cosi (NASDAQ: COSI) gained 9.43% to $1.16. Cosi opened its newest restaurant in the Seaport District in Boston, Massachusetts.

GoPro (NASDAQ: GPRO) jumped 9.06% to $39.00 after surging 31% in its debut on Thursday.

ServiceSource International (NASDAQ: SREV) rose 8.37% to $6.10 after Altai Capital reported a 9.9% stake in ServiceSource.

GW Pharmaceuticals plc (NASDAQ: GWPH) gained 6.07% to $101.98 as Piper Jaffray raised the price target on the stock from $97 to $147.

Alimera Sciences (NASDAQ: ALIM) climbed 5.28% to $6.28 after the company announced the positive Iluvien outcome for the Repeat-Use Procedure.

PPG Industries (NYSE: PPG) shares gained 4.33% to $212.88 after the company announced its plans to buy Consorcio Comex SA de CV for $2.3 billion.

Koninklijke Philips NV (NYSE: PHG) gained 3.51% to $31.54 after the company announced its plans to combine its LED and automotive lighting divisions into a standalone company.

Yahoo! (NASDAQ: YHOO) surged 2.01% to $34.94 after Piper Jaffray upgraded the stock from Neutral to Overweight and raised the target price from $37 to $43.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (CNSL + ALIM)

View Comments and Join the Discussion!

Get Benzinga's Newsletters